10.15.25 -- The Death Of A Dogma: David Baltimore And Lessons For Modern Drug Discovery

Integrating technology with personalized support can ethically, efficiently, and transparently scale patient recruitment, ultimately improving trial outcomes and advancing translational research.

A successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.

Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.

Discover the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.

It’s time to move past per-study custom pre-screeners. Every patient advocacy group, research site, and pharma company “clinical trial finder” website should add condition questionnaires and matching.

Technology transfer – the transmission of bioprocess knowledge, skills, and technology – is a crucial mechanism for ensuring adequate and timely access to innovative medicines.